Aarti Pharmalabs Limited (NSE: AARTIPHARM)
India
· Delayed Price · Currency is INR 623.00
+31.40 (5.31%)
Feb 4, 2025, 3:30 PM IST
Aarti Pharmalabs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Net Income | 2,281 | 2,169 | 1,935 | 1,223 | -0.05 | -0.19 |
| Depreciation & Amortization | 789.46 | 732.35 | 625.43 | 421.19 | - | - |
| Loss (Gain) From Sale of Assets | -1.61 | -5.51 | 4.47 | -0.4 | - | - |
| Provision & Write-off of Bad Debts | 12.24 | 10.68 | 15 | - | - | - |
| Other Operating Activities | 517.09 | 475.51 | 237.64 | 223.3 | - | - |
| Change in Accounts Receivable | -838.7 | -1,255 | -351.72 | -1,025 | 0.05 | - |
| Change in Inventory | -1,161 | -396.64 | -1,267 | -559.92 | - | - |
| Change in Accounts Payable | 488.27 | 433.48 | 1,302 | -718.62 | - | - |
| Operating Cash Flow | 2,113 | 2,164 | 2,501 | -437.04 | - | -0.19 |
| Operating Cash Flow Growth | -15.90% | -13.50% | - | - | - | - |
| Capital Expenditures | -2,604 | -1,556 | -1,021 | -1,412 | - | - |
| Sale (Purchase) of Intangibles | -384.34 | -431.81 | -175.29 | - | - | - |
| Investment in Securities | -10.98 | -188.53 | -391.23 | -0.73 | - | - |
| Other Investing Activities | 76.01 | 30.74 | 9.77 | 24.86 | - | - |
| Investing Cash Flow | -2,923 | -2,146 | -1,578 | -1,387 | - | - |
| Short-Term Debt Issued | - | 499.94 | - | 2,723 | - | - |
| Long-Term Debt Issued | - | - | - | - | - | 0.19 |
| Total Debt Issued | 1,534 | 499.94 | - | 2,723 | - | 0.19 |
| Short-Term Debt Repaid | - | - | -1,243 | - | - | - |
| Long-Term Debt Repaid | - | -49.3 | - | - | - | - |
| Total Debt Repaid | 43.9 | -49.3 | -1,243 | - | - | - |
| Net Debt Issued (Repaid) | 1,578 | 450.64 | -1,243 | 2,723 | - | 0.19 |
| Issuance of Common Stock | - | - | - | - | - | 2.5 |
| Common Dividends Paid | -284.27 | -181.25 | -181.25 | - | - | - |
| Other Financing Activities | -192.16 | -172.15 | -210.52 | -119.59 | - | - |
| Financing Cash Flow | 1,101 | 97.24 | -1,635 | 2,604 | - | 2.69 |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - |
| Net Cash Flow | 290.87 | 115.14 | -711.52 | 779.41 | - | 2.5 |
| Free Cash Flow | -491.25 | 607.5 | 1,480 | -1,849 | - | -0.19 |
| Free Cash Flow Growth | - | -58.95% | - | - | - | - |
| Free Cash Flow Margin | -2.50% | 3.28% | 7.61% | -15.41% | - | - |
| Free Cash Flow Per Share | -5.42 | 6.70 | 16.33 | -20.40 | - | -0.75 |
| Cash Interest Paid | 192.16 | 172.15 | 210.52 | 3.4 | - | - |
| Cash Income Tax Paid | 551.09 | 569.37 | 623.83 | 211.29 | - | - |
| Levered Free Cash Flow | -1,501 | -521.96 | 940.76 | -6,998 | - | - |
| Unlevered Free Cash Flow | -1,379 | -414.37 | 1,072 | -6,995 | - | - |
| Change in Net Working Capital | 1,210 | 1,116 | 103.46 | 7,035 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.